Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;25(3):285-292.
doi: 10.1097/MOT.0000000000000765.

Normothermic machine perfusion of donor-lungs ex-vivo: promoting clinical adoption

Jenny Gilmour  1 , Chelsea Griffiths  1 , Tom Pither  1 , William E Scott 3rd  1 , Andrew J Fisher  1   2
Affiliations
Review

Normothermic machine perfusion of donor-lungs ex-vivo: promoting clinical adoption

Jenny Gilmour et al. Curr Opin Organ Transplant. 2020 Jun.

Abstract

Purpose of review: Lung transplantation offers the only realistic therapeutic option for patients with end-stage lung disease. However, this is impacted by a shortfall in availability of suitable donor-lungs. Normothermic machine perfusion of donor-lungs outside the donor body also known as ex-vivo lung perfusion (EVLP) offers a potential solution through objective assessment, reconditioning and treatment of donor-lungs initially deemed unsuitable for use. This review discusses key advances and challenges in the wider clinical adoption of this technology.

Recent findings: This review will summarize key research within the following areas: recent clinical trials utilizing EVLP, logistical challenges, EVLP protocol innovations, novel assessment methods and current research into therapeutic modulation of lung function during EVLP.

Summary: Normothermic machine perfusion of donor-lungs ex-vivo offers a promising platform to assess and modulate donor-lung quality prior to transplantation. Consensus on how and when to best utilize EVLP is yet to be reached, meaning that widespread clinical adoption of the technology has not yet become a reality. Further work is needed on agreed indications, perfusion protocols and organization of services before becoming a regularly used procedure prior to lung transplantation.

PubMed Disclaimer

References

    1. Punch JD, Hayes DH, LaPorte FB, et al. Organ donation and utilization in the United States, 1996–2005. Am J Transplant 2007; 7 (s1):1327–1338.
    1. Van Raemdonck D, Neyrinck A, Verleden GM, et al. Lung donor selection and management. Proc Am Thoracic Soc 2009; 6:28–38.
    1. NHS blood and transplant: transplant activity report 2019. Available from: https://www.organdonation.nhs.uk/helping-you-to-decide/about-organ-donat....
    1. Sanchez PG, Davis RD, D’Ovidio F, et al. The NOVEL lung trial one-year outcomes. J Heart Lung Transplant 2014; 33:S71–S72.
    1. United therapeutics announces FDA approval of XPS™ and Steen Solution™ used to perform centralized ex-vivo lung perfusion services [press release]; 2019.

Publication types

MeSH terms